CClinicalTrials.gg
RecruitingNCT02533804Updated Dec 6, 2024

The Lake Nona Life Project

An observational study in Health Behavior, Quality of Life and Aging, sponsored by University of Central Florida. Recruiting at 1 site in United States. Open to participants aged 18 Years to 110 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-06.

Sponsored by University of Central Florida · Observational

From the registry’s dates

  • Primary completion was expected by Dec 2025, 9 months ago, but the record still lists the study as recruiting.
  • Started Dec 2014; still recruiting 11 years 9 months later.
Study type
Observational
Model
Ecologic or community
Time perspective
Prospective
Enrollment
10,000
Ages
18 Years to 110 Years
Sex
All
01

Study summary

The Lake Nona Life Project aims to examine the health and wellness of participants over the course of multiple years, focusing on the links between health and wellness, longevity, quality of life, and human performance.

Read the detailed description

The Lake Nona Life Project is a community health and wellness research project of the Lake Nona Institute (LNI), carried out by the Lake Nona Medical City Residents and Partners (the Researchers), and sponsored by Florida Hospital. The project is designed to study patterns, predictors and strategies for improving human health and wellness. Data will be obtained over many years using surveys/interviews, medical tests, and health information from 3rd parties (i.e., health care claims data) obtained with participant permission.

02

Conditions studied

  • Health Behavior
  • Quality of Life
  • Aging

Keywords

  • health
  • wellness
  • life expectancy
  • quality of life
  • performance
  • religion
  • skin
  • cardiovascular
  • joints
  • bone
  • respiration
  • pain
  • nervous system diseases
  • oral health
  • behavior
  • child
  • depression
  • mood
  • panic
  • sleep
  • stress
  • nutrition
  • exercise
  • life change events
  • personality
  • employment
  • social networking
  • time management
  • residence characteristics
03

In context

Lead sponsor

University of Central Florida is the lead sponsor of 99 studies on the registry; 40 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 110 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Adults ages 18 and older living and/or working in the Lake Nona Community (proper) of Orlando, Florida.

Inclusion criteria

  • 18 years or older
  • Live and/or work in the Lake Nona Community (proper)
  • Able to provide informed consent
  • Able to speak and read English

Exclusion criteria

Exclusion Criteria:

  • Unable to speak or communicate in English
  • Living outside of the LNLP study map
  • Cognitive impairment that would not allow survey completion
  • Unable to speak and read English
05

Study design

Observational model
Ecologic or community
Time perspective
Prospective
Enrollment
10,000 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Quality of Life over 10 Years

    Participants will self report on an Investigator created questionnaire regarding life satisfaction, stress and life events. Responses will be provided on a five point Likert Scale.

    Time frame: 20 years

Secondary outcomes

  1. Demographics

    Participants will self report demographic information consisting of questions related to age, gender and race.

    Time frame: 20 years

  2. Medical History

    Participants will self report medical history and chronic conditions.

    Time frame: 20 years

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Institute for Health Metrics and Evaluation. 2013. Financing Global Health 2012: The End of the Golden Age? Seattle, WA: IHME http://www.healthmetricsandevaluation.org/publications/policy-report/financing-global-health-2012-end-golden-age
  • World Health Organization. (2012). World Health Statistics 2012. Geneva, Switzerland: World Health Organization http://www.who.int/gho/publications/world_health_statistics/EN_WHS2012_TOC.pdf?ua=1
  • United Nations, Department of Economic and Social Affairs, Population Division. (2011). World population prospects, the 2010 revision. http://esa.un.org/unpd/wpp/Documentation/WPP%202010%20publications.htm
  • Organization for Exonomic Co-operation and Development. (2012). OECD Health Data 2012: U. S. Health Care System from an International Perspective [PDF document]. Retrieved from http://www.oecd.org/health/HealthSpendingInUSA_HealthData2012.pdf
  • US Central Intelligence Agency. (2014). The World Factbook, Country Comparison: Life Expectancy at Birth. Retrieved from https://www.cia.gov/library/publications/the-world-factbook/rankorder/2102rank.html
  • Murphy SL, Xu J, Kochanek KD. Deaths: final data for 2010. Natl Vital Stat Rep. 2013 May 8;61(4):1-117. PubMed 24979972 ↗
  • Rand Health. (2000). Projection of chronic illness prevalence and cost inflation. Santa Monica, CA: Wu, S., Y., Green, A.
  • Kung HC, Hoyert DL, Xu J, Murphy SL. Deaths: final data for 2005. Natl Vital Stat Rep. 2008 Apr 24;56(10):1-120. PubMed 18512336 ↗
  • National Center for Chronic Disease Prevention and Health Promotion. (2012). Chronic Diseases and Health Promotion. Retrieved from http://www.cdc.gov/chronicdisease/overview/index.htm
  • Adams PF, Kirzinger WK, Martinez ME. Summary health statistics for the u.s. Population: national health interview survey, 2011. Vital Health Stat 10. 2012 Dec;(255):1-110. PubMed 25116371 ↗
  • National Heart, Lung, and Blood Institute, Boston University. (2014). The Framingham Heart Study Bibliography. Retrieved from http://www.framinghamheartstudy.org/fhs-bibliography/index.php
  • Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash). 2003 Mar-Apr;43(2):173-84. doi: 10.1331/108658003321480713. PubMed 12688435 ↗
  • Bunting BA, Cranor CW. The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc (2003). 2006 Mar-Apr;46(2):133-47. doi: 10.1331/154434506776180658. PubMed 16602223 ↗
  • Bunting BA, Smith BH, Sutherland SE. The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia. J Am Pharm Assoc (2003). 2008 Jan-Feb;48(1):23-31. doi: 10.1331/JAPhA.2008.07140. PubMed 18192127 ↗
  • Luepker RV, Murray DM, Jacobs DR Jr, Mittelmark MB, Bracht N, Carlaw R, Crow R, Elmer P, Finnegan J, Folsom AR, et al. Community education for cardiovascular disease prevention: risk factor changes in the Minnesota Heart Health Program. Am J Public Health. 1994 Sep;84(9):1383-93. doi: 10.2105/ajph.84.9.1383. PubMed 8092360 ↗
  • Belloc NB, Breslow L. Relationship of physical health status and health practices. Prev Med. 1972 Aug;1(3):409-21. doi: 10.1016/0091-7435(72)90014-x. No abstract available. PubMed 5085007 ↗
  • GORDON T. Mortality experience among the Japanese in the United States, Hawaii, and Japan. Public Health Rep (1896). 1957 Jun;72(6):543-53. No abstract available. PubMed 13432134 ↗
  • Yano K, Reed DM, McGee DL. Ten-year incidence of coronary heart disease in the Honolulu Heart Program. Relationship to biologic and lifestyle characteristics. Am J Epidemiol. 1984 May;119(5):653-66. doi: 10.1093/oxfordjournals.aje.a113787. PubMed 6720665 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 6, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02533804
Lead sponsor
University of Central Florida
Collaborators
Lake Nona Institute, DataStat, Inc., Mytrus, Inc.
Responsible party
Sponsor
First posted
Aug 27, 2015
Start date
Dec 31, 2014
Primary completion
Dec 31, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Dec 6, 2024

Study contacts

Ashley Kohrt
Contact
ashley.kohrt@flhosp.org
Jasmine Jones
Contact
jasmine.jones@flhosp.org
Patricia Robinson
principal investigator · Center for CREATION Health Research

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion